Efficacy and safety of Wenxin Granules in treatment of chronic heart failure with atrial fibrillation: a systematic review.
10.19540/j.cnki.cjcmm.20190321.501
- Author:
Yu XIN
1
;
Yan-Yan DAI
1
;
Hao-Xin YANG
1
;
Xiu-Wen ZHANG
1
;
Bo LI
2
Author Information
1. Dongzhimen Hospital,Beijing University of Chinese Medicine Beijing 100700,China.
2. Beijing Institute of Traditional Chinese Medicine,Beijing Hospital of Traditional Chinese Medicine,Capital Medical University Beijing 100010,China Yanqing Hospital,Beijing Hospital of Traditional Chinese Medicine,Capital Medical University Beijing 102100,China.
- Publication Type:Systematic Review
- Keywords:
Wenxin Granules;
atrial fibrillation;
heart failure;
randomized controlled trial;
systematic review
- MeSH:
Atrial Fibrillation/drug therapy*;
Drugs, Chinese Herbal/therapeutic use*;
Heart Failure/drug therapy*;
Humans;
Randomized Controlled Trials as Topic;
Stroke Volume;
Ventricular Function, Left
- From:
China Journal of Chinese Materia Medica
2019;44(23):5198-5206
- CountryChina
- Language:Chinese
-
Abstract:
This systematic review aims to evaluate the efficacy and safety of Wenxin Granules in the treatment of chronic heart failure with atrial fibrillation. Databases,such as CNKI,Wan Fang Date,VIP,PubMed,Cochrane Library,were electronically retrieved for relevant randomized controlled trials of Wenxin Granules in the treatment of chronic heart failure with atrial fibrillation. Two researchers independently screened out the literatures,extracted data according to the inclusion criteria,and conducted a quality assessment by the risk bias assessment tool in the Cochrane evaluation manual. Cochrane systematic evaluation software Rev Man 5. 3 was used for data analysis. Totally 11 randomized controlled trials,including 941 subjects. The intervention measures were the conventional treatment recommended by the guidelines combined with Wenxin Granules; and the control measures were the conventional treatment recommended by the guidelines alone. The results showed that compared with conventional treatment alone,Wenxin Granules combined with conventional treatment can better reduce the BNP level in patients with heart failure with atrial fibrillation( MD =-258. 18,95% CI[-464. 06,-52. 30],P= 0. 01) or NT-proBNP level,better improve left ventricular ejection fraction( MD = 6. 72,95%CI[4. 61,8. 84],P<0. 000 01),I~2= 65%,And the ventricular rate decreased more significantly( MD =-11. 66,95% CI[-15. 79,-7. 54],P<0. 000 01),and the cardiac function was improved more efficiently( RR = 1. 20,95%CI [1. 11,1. 31],P<0. 000 1),I~2= 23%.In conclusion,compared with the single administration of conventional Western medicine,the combined administration of Wenxin Granules has better effects in reducing the level of BNP or NT-proBNP,slowing down the ventricular rate,and improving the left ventricular ejection fraction,with fewer adverse reactions. However,due to the small sample size and the low quality of literatures included in this systematic review,it is shall be carefully applied in clinic. More rigorous randomized controlled trials shall be conducted to determine the efficacy of Wenxin Granules in improving cardiac function in the treatment of chronic heart failure with atrial fibrillation.
